YD Bio Limited (NASDAQ:YDES – Get Free Report)’s share price traded up 18.1% on Tuesday . The stock traded as high as $4.00 and last traded at $3.98. Approximately 86,836 shares were traded during mid-day trading, an increase of 146% from the average session volume of 35,311 shares. The stock had previously closed at $3.37.
YD Bio Trading Up 9.6%
The company has a 50-day moving average of $2.49 and a 200-day moving average of $5.22.
Hedge Funds Weigh In On YD Bio
An institutional investor recently raised its stake in YD Bio stock. Geode Capital Management LLC boosted its position in YD Bio Limited (NASDAQ:YDES – Free Report) by 10.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 58,363 shares of the biotechnology company’s stock after buying an additional 5,292 shares during the period. Geode Capital Management LLC owned approximately 0.08% of YD Bio worth $711,000 at the end of the most recent quarter.
About YD Bio
YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.
Recommended Stories
- Five stocks we like better than YD Bio
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
- Sociedad Química y Minera’s Lithium Boom Is Back, But Iodine Steals the Show
Receive News & Ratings for YD Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for YD Bio and related companies with MarketBeat.com's FREE daily email newsletter.
